ArriVent BioPharma
AVBP
#5767
Rank
$0.87 B
Marketcap
$25.87
Share price
-0.84%
Change (1 day)
N/A
Change (1 year)

ArriVent BioPharma (AVBP) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $0.31 Billion USD

According to ArriVent BioPharma's latest financial reports the company's total liabilities are $0.31 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ArriVent BioPharma - Total liabilities on balance sheet (from 2022 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31$0.26 B14638.28%
2021-12-31$1.81 M